A clinical discussion with Gregory
B. Holm, PhD, ARNP-C; Hosted by Frances M. Sahebzamani,
PhD, ARNP
Dr. Gregory B. Holm from the University of South Florida in
Tampa talks with CE-TODAY about treating the pain syndromes
most commonly seen in the primary care setting, offers insight into
pain pathways, and emphasizes the importance of a thorough pain assessment.
Overview
After years of neglect, issues of
pain assessment and management have captured the attention of both
health care professionals and the public. Factors that prompted
such attention include the high prevalence of pain, continuing evidence
that pain is under-treated and a growing awareness of the adverse
consequences of inadequately managed pain.
Pain is common – the most common reason individuals
seek health care. Chronic pain is the most common cause of long-term
disability and almost one third of all Americans will experience
severe chronic pain at some point in their lives. Improved understanding
of pain and increasingly effective medications should enable effective
pain management for most people with acute or chronic pain. Yet
recent studies suggest that many types of pain are under-treated.
This course provides an update on the current understanding
of pharmacologic and nonpharmacologic interventions, identifies
the primary goals of chronic pain management, and presents a comprehensive
approach to patient care that incorporates physiologic treatment,
stress management, behavior modification, and promotion of patient
self-efficacy.
Upon completion of this course,
you should be able to:
Identify three primary goals of chronic pain management
Relate the psychosocial aspects of pain presentation
to the overall plan of care
Select appropriate pharmacologic and nonpharmacologic
interventions in the treatment of pain
Target Audience
This
CE activity is designed for nurse practitioners as well as other
healthcare providers who are involved in the diagnosis and treatment
of patients with chronic pain.
Gregory
B. Holm, PhD, ARNP-C[BioSketch] Assistant Professor, University of South
Florida Colleges of Medicine & Nursing, Tampa, Florida; Practitioner,
Lakeside Occupational Medical Centers, Pennsylvania Disclosure: Speaker's Bureau: Pfizer.
Frances
M. Sahebzamani, PhD, ARNP[BioSketch] Assistant Professor, Assistant Director
of Research, Department of Family Medicine; Co-Director, USF Prediabetes
Treatment and Research Center, University of South Florida, Tampa,
Florida Disclosure: Advisory Board: Eli Lilly, Merck; Presenter:
Pfizer, KOS Pharmaceuticals, Inc.
Accreditation Statement
This program has been
granted 1.0 contact hour of continuing education (which includes
0.5 hours of pharmacology) by the American Academy of Nurse Practitioners,
course number 0405216.
Accreditation Period
This program
was initially published on July 20, 2004, and is eligible for credit
through July 20, 2006.
Course Certificate Fees
This course certificate is FREE to
the holders of this issue of CE-TODAY™
for Nurse Practitioners or the companion CEonCD™.*
All others will be assessed a $10.00 USD processing fee per credit
hour.
*Valid only during the free offer period
listed on the CD-ROM.
